Search Results

There are 193335 results for: content related to: Salvage Therapy for Acute Myeloid Leukemia: Current Strategies and Emerging Therapies

  1. You have free access to this content
    Flavopiridol inhibits lipopolysaccharide-induced TNF-α production through inactivation of nuclear factor-κB and mitogen-activated protein kinases in the MyD88-dependent pathway

    Microbiology and Immunology

    Volume 55, Issue 3, March 2011, Pages: 160–167, Abedul Haque, Naoki Koide, Imtiaz Iftakhar-E-Khuda, Abu Shadat Mohammod Noman, Erdenezaya Odkhuu, Battuvshin Badamtseren, Yoshikazu Naiki, Takayuki Komatsu, Tomoaki Yoshida and Takashi Yokochi

    Article first published online : 23 FEB 2011, DOI: 10.1111/j.1348-0421.2010.00304.x

  2. Intracellular Signaling Kinase Inhibitors

    Targeting Protein Kinases for Cancer Therapy

    David J. Matthews, Mary E. Gerritsen, Pages: 567–621, 2010

    Published Online : 11 MAR 2010, DOI: 10.1002/9780470555293.ch10

  3. Flavopiridol as a radio-sensitizer for esophageal cancer cell lines

    Diseases of the Esophagus

    Volume 17, Issue 4, December 2004, Pages: 338–344, S. Sato, Y. Kajiyama, M. Sugano, Y. Iwanuma and M. Tsurumaru

    Article first published online : 24 NOV 2004, DOI: 10.1111/j.1442-2050.2004.00437.x

  4. Rational Drug Design of Small Molecule Anticancer Agents: Early Clinical Development

    Standard Article

    The Cancer Handbook

    Rhoda Molife, Ian Collins, Paul Workman and Stan B. Kaye

    Published Online : 15 OCT 2007, DOI: 10.1002/9780470025079.chap315

  5. You have full text access to this OnlineOpen article
    Cell cycle-independent induction of apoptosis by the anti-tumor drug flavopiridol in endothelial cells

    International Journal of Cancer

    Volume 77, Issue 1, 3 July 1998, Pages: 146–152, Sabine Brüsselbach, Dirk M. Nettelbeck, Hans-Harald Sedlacek and Rolf Müller

    Article first published online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19980703)77:1<146::AID-IJC22>3.0.CO;2-B

  6. You have full text access to this OnlineOpen article
    CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer cells compared to flavopiridol

    International Journal of Cancer

    Volume 130, Issue 5, 1 March 2012, Pages: 1216–1226, Xiangrui Liu, Shenhua Shi, Frankie Lam, Chris Pepper, Peter M. Fischer and Shudong Wang

    Article first published online : 21 JUN 2011, DOI: 10.1002/ijc.26127

  7. Preclinical study of treatment response in HCT-116 cells and xenografts with 1H-decoupled 31P MRS

    NMR in Biomedicine

    Volume 24, Issue 9, November 2011, Pages: 1159–1168, Moses M. Darpolor, Peter T. Kennealey, H. Carl Le, Kristen L. Zakian, Ellen Ackerstaff, Asif Rizwan, Jin-Hong Chen, Elliot B. Sambol, Gary K. Schwartz, Samuel Singer and Jason A. Koutcher

    Article first published online : 24 MAR 2011, DOI: 10.1002/nbm.1674

  8. You have full text access to this OnlineOpen article
    Cyclin-dependent kinase inhibitor, flavopiridol, induces apoptosis and inhibits tumor growth in drug-resistant osteosarcoma and Ewing's family tumor cells

    International Journal of Cancer

    Volume 121, Issue 6, 15 September 2007, Pages: 1212–1218, Yan Li, Kazuhiro Tanaka, Xu Li, Takamitsu Okada, Tomoyuki Nakamura, Minoru Takasaki, Shunsaku Yamamoto, Yoshinao Oda, Masazumi Tsuneyoshi and Yukihide Iwamoto

    Article first published online : 22 MAY 2007, DOI: 10.1002/ijc.22820

  9. You have full text access to this OnlineOpen article
    Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells

    International Journal of Cancer

    Volume 116, Issue 3, 1 September 2005, Pages: 385–394, Xu Li, Kazuhiro Tanaka, Fumihiko Nakatani, Tomoya Matsunobu, Riku Sakimura, Masuo Hanada, Takamitsu Okada, Tomoyuki Nakamura and Yukihide Iwamoto

    Article first published online : 7 APR 2005, DOI: 10.1002/ijc.21010

  10. Cyclin-Dependent Kinase 9 Inhibition Protects Cartilage From the Catabolic Effects of Proinflammatory Cytokines

    Arthritis & Rheumatology

    Volume 66, Issue 6, June 2014, Pages: 1537–1546, Jasper H. N. Yik, Zi'ang Hu, Ratna Kumari, Blaine A. Christiansen and Dominik R. Haudenschild

    Article first published online : 27 MAY 2014, DOI: 10.1002/art.38378

  11. Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil

    Acta Pharmacologica Sinica

    Volume 27, Issue 10, October 2006, Pages: 1375–1381, Jun GUO, An-wu ZHOU, Yu-cai FU, Udit N VERMA, Debu TRIPATHY, Eugene PFRENKEL and Carlos R BECERRA

    Article first published online : 11 OCT 2006, DOI: 10.1111/j.1745-7254.2006.00421.x

  12. Clinical Pharmacokinetics of Flavonoids

    Flavonoid Pharmacokinetics: Methods of Analysis, Preclinical and Clinical Pharmacokinetics, Safety, and Toxicology

    Casey L. Sayre, Karen D. Gerde, Jaime A. Yáñez, Neal M. Davies, Pages: 195–247, 2012

    Published Online : 5 NOV 2012, DOI: 10.1002/9781118468524.ch5

  13. Assaying pharmacodynamic endpoints with targeted therapy: Flavopiridol and 17AAG induced dephosphorylation of histone H1.5 in acute myeloid leukemia


    Volume 10, Issue 23, No. 23 December 2010, Pages: 4281–4292, Liwen Wang, Sean W. Harshman, Shujun Liu, Chen Ren, Hua Xu, Larry Sallans, Michael Grever, John C. Byrd, Guido Marcucci and Michael A. Freitas

    Article first published online : 26 NOV 2010, DOI: 10.1002/pmic.201000080

  14. You have full text access to this OnlineOpen article
    Delayed combinatorial treatment with flavopiridol and minocycline provides longer term protection for neuronal soma but not dendrites following global ischemia

    Journal of Neurochemistry

    Volume 105, Issue 3, May 2008, Pages: 703–713, Grace O. Iyirhiaro, Tyson B. Brust, Juliet Rashidian, Zohreh Galehdar, Aweis Osman, Maryam Phillips, Ruth S. Slack, Brian A. MacVicar and David S. Park

    Article first published online : 6 DEC 2007, DOI: 10.1111/j.1471-4159.2007.05166.x

  15. You have free access to this content
    Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor

    British Journal of Pharmacology

    Volume 171, Issue 1, January 2014, Pages: 55–68, T K Albert, C Rigault, J Eickhoff, K Baumgart, C Antrecht, B Klebl, G Mittler and M Meisterernst

    Article first published online : 10 DEC 2013, DOI: 10.1111/bph.12408

  16. Identification of Flavopiridol Analogues that Selectively Inhibit Positive Transcription Elongation Factor (P-TEFb) and Block HIV-1 Replication


    Volume 10, Issue 12, August 17, 2009, Pages: 2072–2080, Akbar Ali, Animesh Ghosh, Robin S. Nathans, Natalia Sharova, Siobhan O'Brien, Hong Cao, Mario Stevenson and Tariq M. Rana

    Article first published online : 14 JUL 2009, DOI: 10.1002/cbic.200900303

  17. You have full text access to this OnlineOpen article
    The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation

    The EMBO Journal

    Volume 27, Issue 13, July 9, 2008, Pages: 1907–1918, Sonja Baumli, Graziano Lolli, Edward D Lowe, Sonia Troiani, Luisa Rusconi, Alex N Bullock, Judit É Debreczeni, Stefan Knapp and Louise N Johnson

    Article first published online : 19 JUN 2008, DOI: 10.1038/emboj.2008.121

  18. Sequential combinations of flavopiridol and docetaxel inhibit prostate tumors, induce apoptosis, and decrease angiogenesis in the Gγ/T-15 transgenic mouse model of prostate cancer

    The Prostate

    Volume 66, Issue 14, 1 October 2006, Pages: 1487–1497, Teresita Reiner, Alicia de las Pozas and Carlos Perez-Stable

    Article first published online : 18 AUG 2006, DOI: 10.1002/pros.20478

  19. Cell Cycle Control

    Targeting Protein Kinases for Cancer Therapy

    David J. Matthews, Mary E. Gerritsen, Pages: 327–390, 2010

    Published Online : 11 MAR 2010, DOI: 10.1002/9780470555293.ch6

  20. BCRP (ABCG2)

    Pharmacogenomics of Human Drug Transporters: Clinical Impacts

    Agnes Basseville, Susan E. Bates, William D. Figg, Alex Sparreboom, Pages: 311–343, 2013

    Published Online : 15 MAR 2013, DOI: 10.1002/9781118353240.ch14